- Home
- MRK vs MRVL Comparison
MRK vs MRVL Comparison
Compare MRK & MRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | MRVL |
|---|---|---|
| Founded | 2000 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 159.9B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MRK | MRVL |
|---|---|---|
| Price | $119.05 | $280.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 32 |
| Target Price | ★ $125.59 | $120.28 |
| AVG Volume (30 Days) | 7.8M | ★ 44.4M |
| Earning Date | 04-30-2026 | 05-28-2026 |
| Dividend Yield | ★ 3.06% | 0.15% |
| EPS Growth | 8.01 | ★ 400.98 |
| EPS | N/A | ★ 0.04 |
| Revenue | ★ $65,011,000,000.00 | $8,194,600,000.00 |
| Revenue This Year | $3.61 | $35.14 |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | ★ N/A | $7,010.00 |
| Revenue Growth | 1.31 | ★ 42.09 |
| 52 Week Low | $76.66 | $61.44 |
| 52 Week High | $125.14 | $324.20 |
Technical Indicators
Market Signals| Indicator | MRK | MRVL |
|---|---|---|
| Relative Strength Index (RSI) | 55.45 | 64.18 |
| Support Level | $112.96 | $76.86 |
| Resistance Level | $123.93 | $324.20 |
| Average True Range (ATR) | 2.89 | 28.00 |
| MACD | 0.22 | 1.44 |
| Stochastic Oscillator | 56.59 | 69.15 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About MRVL Marvell Technology Inc.
Marvell Technology is a fabless chip designer focused on wired networking, where it has the second-highest market share. Marvell serves the data center, carrier, enterprise, and consumer end markets with processors, optical and copper transceivers, switches, and storage controllers.